SCHEMBL20624944

SCHEMBL20624944

CS(=O)(=O)CC1COC2(CCCCC2)O1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
GAA P10253 1/20 0.47
ALDH1A1 P00352 2/20 0.40
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
BRD4 O60885 1/20 0.39
ABL1 P00519 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
RIN1 Q13671 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR1A P08908 6/20 0.39
ADRA1D P25100 5/20 0.39
ADRA1B P35368 5/20 0.39
ADRA1A P35348 4/20 0.38
CA2 P00918 6/20 0.36
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13381099 0.83 PABPC1 (0.59) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL18885118 0.83 PABPC1 (0.59) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL21987642 0.82 PABPC1 (0.47) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL13381093 0.81 PABPC1 (0.56) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL8590387 0.80 CA2 (0.49) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL17913675 0.77 CA2 (0.56) ALDH1A1TMEM97SIGMAR1SMN1; SMN2CA2
SCHEMBL17913676 0.77 CA2 (0.56) ALDH1A1TMEM97SIGMAR1SMN1; SMN2CA2
SCHEMBL13381097 0.77 PABPC1 (0.51) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL12943471 0.74 PABPC1 (0.54) PABPC1CTDSP1GAAALDH1A1TMEM97
SCHEMBL1487109 0.73 PABPC1 (0.53) PABPC1CTDSP1GAAALDH1A1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed